| Identification | |
| Name: | 3-Quinolinecarboxamide,N-[2-[[[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]amino]carbonyl]-4,5-dimethoxyphenyl]- |
| Synonyms: | Tariquidar;XR 9576 |
| CAS: | 206873-63-4 |
| Molecular Formula: | C38H38 N4 O6 |
| Molecular Weight: | 646.73 |
| InChI: | InChI=1/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.276g/cm3 |
| Refractive index: | 1.662 |
| Specification: |
?Tariquidar (CAS NO.206873-63-4) is also called?Tariquidar [USAN]?; 3-Quinolinecarboxamide,N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)- ; N-(2-((4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide ; XR9576 ;?UNII-J58862DTVD ; 3-Quinolinecarboxamide, N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)- ; N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide .?Tariquidar (CAS NO.206873-63-4) is an P-glycoprotein inhibitor undergoing research for the treatment of cancer. |
| Safety Data | |
 |
|
